Company Profiles

driven by the PitchBook Platform

ApoCell

Description

Provider of molecular biomarker detection and analysis services designed to measure biomarker signatures in clinical trial subjects. The company's molecular biomarker detection and analysis services include monitoring the effectiveness of various types of drugs by measuring biomarker expression patterns in biopsies, blood and rare cell types, enabling clinicians to understand pharmacodynamics of a drug candidate and facilitate patient stratification, thus enhancing clinical trial success.

2004

Founded

PRIVATE

Status

11-50

Employees

Grant

Latest Deal Type

$1M

Latest Deal Amount

$6.44M

Total Amount Raised

Description

Provider of molecular biomarker detection and analysis services designed to measure biomarker signatures in clinical trial subjects. The company's molecular biomarker detection and analysis services include monitoring the effectiveness of various types of drugs by measuring biomarker expression patterns in biopsies, blood and rare cell types, enabling clinicians to understand pharmacodynamics of a drug candidate and facilitate patient stratification, thus enhancing clinical trial success.

Website:

www.apocell.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology
Other Pharmaceuticals and Biotechnology

Primary Office

2575 West Bellfort Suite 190 Houston, TX 77054United States +1 (713) 440-6070
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore ApoCell's full profile, request a free trial.

ApoCell Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

ApoCell Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

ApoCell Investors (2)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Small Business Innovation ResearchGovernment000 0000000 0000
Summit PartnersGrowth/ExpansionMinority000 0000000 0000
Small Business Innovation Research Government
Summit Partners Growth/Expansion

ApoCell Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Darren Davis Ph.DFounder, President & Chief Executive Officer
Jason LowryDirector, Business Development
Cherie Dantone Ph.DDirector, Scientific Liaison
Frank VazquezVice President, Business Development & Marketing
David HasegawaVice President, Product Development
Darren Davis Ph.D Founder, President & Chief Executive Officer
Jason Lowry Director, Business Development
Cherie Dantone Ph.D Director, Scientific Liaison
Frank Vazquez Vice President, Business Development & Marketing
David Hasegawa Vice President, Product Development

ApoCell Board Members (4)

NameRepresentingRoleSinceContact
Info
David McWilliamsSelfChairman000 0000
Rick Ryan Ph.DSelfBoard Member000 0000
Thomas JenningsSummit PartnersManaging Director000 0000
William Dore' Jr.ApoCellBoard Member000 0000
David McWilliams Chairman Self
Rick Ryan Ph.D Board Member Self
Thomas Jennings Managing Director Summit Partners
William Dore' Jr. Board Member ApoCell
Request full access to PitchBook